Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease

Hamid Moradi, Christina Park, Miki Igarashi, Elani Streja, Donovan A. Argueta, Melissa Soohoo, Jennifer Daglian, Amy S. You, Connie M. Rhee, Moti L. Kashyap, Nicholas V. DiPatrizio, Nosratola D. Vaziri, Kamyar Kalantar-Zadeh & Daniele Piomelli
Context: Previous studies have shown that the endocannabinoid system plays a major role in energy metabolism through the actions of its main mediators, 2-arachidonoyl-sn-glycerol (2-AG) and anandamide (AEA). Objective: We examined serum levels of major endocannabinoid mediators and their association with clinical parameters in patients with end-stage renal disease (ESRD). Design and Setting: Serum concentrations of 2-AG and AEA were measured in patients on maintenance hemodialysis (MHD), and correlations with various clinical and laboratory indices...
211 views reported since publication in 2019.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?
51 downloads reported since publication in 2019.

These counts follow the COUNTER Code of Practice, meaning that Internet robots and repeats within a certain time frame are excluded.
What does this mean?